A technique of fetoscopy and fetoscopic blood sampling is described that makes maximum use of ultrasound scanning. A particle size analyser is also an integral part of the procedure. The results are based on 170fetoscopies, 85 of which were performed for diagnostic reasons. The anterior placenta is rarely a cause of failure and in many instances makes fetal blood sampling easier. Pure fetal blood is obtainable from the umbilical cord insertion in 95% of cases sampled after 18 weeks' gestation. Fetal mortality may be as low as 3%and long-term adverse sequelae have not yet been discovered.
Introduction
Until recently, fetoscopy has been a piped ream of the obstetrician anti the geneticist. The possibility of penetrating the uterus to inspect the fetus or to acquire tissues from it held great promise, but development was slow because of inadequate technology, potential risks to mother and fetus, and because relatively few patients would benefit. Scrimgeour (1973) was the first to allow pregnancies to continue after fetoscopic examination and Valenti (1972 Valenti ( , 1973 first took fetal blood and skin biopsies, albeit in experimental circumstances at termination of pregnancy. Both authors made their entry into the uterus after exposing it by a laparotomy. With the development of the Needlescope (Dyonics Inc, Woburn, Mass), which could be inserted transabdominally under local anaesthesia (Hobbins et 01. 1974) , fetoscopy became feasible as a clinical procedure. Fetal red cells, usually mixed with amniotic fluid, and often also with maternal blood, could be collected from the fetal vessels on the chorionic plate of the placenta for the diagnosis of haemoglobinopathies in utero ). There were still, however, severe limitations in that pure fetal blood could not be obtained for the assay of substances in fetal plasma, and the once widely held view that an anterior placenta was regarded as a contraindication to fetoscopy.
Methods
The cannula measures 2.2 x 2.7 mm in cross section since it has a side channel for the 27 gauge blood sampling needle. The cannula and its trocar are inserted into the amniotic cavity under local anaesthesia and the latter is replaced by the Needlescope shaft, 1.7 mm in diameter. The technique for fetal examination and for fetal blood sampling has been described elsewhere (Rodeck & Campbell 19780, b, 1979) .
It is worth emphasizing the central importance of ultrasonic examination both before and during the procedure; indeed it is preferable if the fetoscopist does the scanning himself. A preliminary scan will check the gestational age, confirm fetal number and life, and ensure the optimal timing of the fetoscopy, i.e. 15 to 17 weeks for fetal examination and 18to 22 weeks for fetal blood sampling. Where amniocentesis is necessary before fetoscopy, e.g. to determine the fetal sex in a haemophilia carrier, this should be carried out under direct ultrasound guidance to minimize the chances of intra-amniotic bleeding. A clear tap does not necessarily preclude bleeding since it can occur after withdrawal of the needle, particularly if the placenta has been traversed, and the resultant turbidity may persist for weeks and make a subsequent fetoscopy impossible. Ideally, the fetoscopist should perform the amniocentesis himself and there is then no one else to blame! There are other important advantages: he gets to know the At fetoscopy, a real-time scanner is used with the transducer wrapped in a sterile polythene bag and sterile oil for acoustic coupling. The preparatory scan must be carefully done (again preferably by the fetoscopist himself) and the crucial decision of where to insert the trocar and cannula is made. This frequently takes longer than the fetoscopy itself and several factors have to be noted as they influence the insertion site: (a) the placental site and margin; (b) the position of the fetus; (c) the distribution of amniotic fluid; (d) the location of the umbilical cord insertion. The latter is the optimal place for aspiration of pure fetal blood from within the lumen of a fetal vessel: withdrawal of the needle from the vessel results in much less intraamniotic haemorrhage than occurs when the chorionic plate vessels are sampled; neither is puncture at this site associated with changes in the fetal heart rate (C H Rodeck, K Hertogs & U Nicolini, in preparation). Sampling is often easier when the placenta is anterior because the silhouette ofthe cord insertion is seen like an inverted tree trunk and the needle approaches it perpendicularly. The posterior cord insertion may be more difficult partly because the fetus may cover it and partly because the direction of puncture is more nearly parallel to the direction of the cord. Furthermore, the posterior placenta can be treacherous if it bulges forward, creating a uterus with a shallow amniotic cavity, rather like a hot-water bottle; such placentas are easily grazed on insertion of trocar and cannula, resulting in troublesome bleeding and a poor view.
Peroperatively the patient receives 1 g cephradine intravenously. Postoperatively salbutamol is infused intravenously for six hours; subsequently, 4 mg three times a day is given orally for one week. Provided there are no contraindications, the patient leaves hospital the next day.
Results
One hundred and seventy fetoscopies have been performed at King's College Hospital, 85 of which were diagnostic. The remaining patients were admitted for termination of pregnancy and, informed consent having been obtained, the fetoscopy was performed immediately before intra-amniotic instillation of prostaglandin E z and 18% saline. In 130 of the 170 fetoscopies fetal blood sampling was attempted. Table 1 presents the results obtained in the last 109consecutive attempts at fetal blood sampling, starting with the first case (the 22nd) in which pure fetal blood was aspirated. The first 21 fetoscopies are excluded (although many had yielded samples consisting of 100% fetal red cells diluted with amniotic fluid). Table 1 shows the success rate in obtaining pure fetal blood related to gestational age. Overall, this is 88%; when sampling is performed between 15 and 17 weeks' gestation it is only 68%, but between 18 and 23 weeks it rises to 95%. The mean amount of pure fetal blood withdrawn was 615 J.l.l (range 50-1000) and the mean duration of the procedure was 18.4 minutes (range 5-38). The criteria for purity offetal blood have been defined elsewhere (Rodeck & Campbelll978b, 1979) .The placenta was predominantly anterior in 46% and mainly posterior or fundal in 54% of patients.
Diagnostic fetoscopies
In Table 2 the diagnostic indications for obtaining fetal blood in 71 fetoscopies are shown. In three patients a repeat fetoscopy was needed because of laboratory difficulties and not because of sampling failure at the first fetoscopy. These all occurred in the thalassaemia group. In two patients, no fetal blood sample was obtained: one was a possible carrier of Duchenne muscular dystrophy who had elected to terminate the pregnancy regardless of the fetal plasma creatine kinase level; the second patient had an extremely extensive anterior placenta which was damaged by the trocar, resulting in heavy intra-amniotic maternal bleeding, placental abruption and intrauterine death. With regard to the prenatal diagnosis of~thalassaemia (Professor J M White, King's College Hospital; Dr Bernadette Modell, University College Hospital), in 13 instances the diagnosis was~thalassaemia major, in 21 it was thalassaemia trait, and in 8 the fetus was normal; no diagnosis could be made in the intrauterine death (see above). Thirteen pregnancies have been terminated and 7 unaffected babies have been born; there have been no diagnostic errors.
The prenatal diagnosis of haemophilia is now feasible (Mibashan et 01. 1979), but that of Duchenne muscular dystrophy is still at an experimental stage since false negatives have been reported with creatine kinase assay (Golbus et 01. 1979) .
The case of galactosaemia has been the subject of a separate report (Fensom et 01. 1979 ). The fetus whose mother had had acute toxoplasmosis in early pregnancy showed no evidence of specific IgM in its plasma, but the mother elected to terminate the pregnancy. No signs of infection could be found in the fetal tissues (Dr Fleck, St George's Hospital). Table 3 lists the indications for fetal examination in 14 fetoscopies. The diagnosis was excluded in all and no pregnancy in this group was terminated. On the contrary, it was possible to avoid termination in many patients who had requested this on grounds of high fetal risk, by reassuring them that their baby did not have the anomaly. One patient aborted a normal fetus one week after the fetoscopy; there is almost certainly a causal relationship as the procedure was prolonged (45 min) due to an unfavourable fetal position. Ten women have delivered healthy babies and 3 pregnancies are still continuing. Table 4 summarizes the outcome of 85 fetoscopies in 82 patients.
Discussion
Fetal blood can be obtained by several methods. Placentocentesis ('blind' placental aspiration) was first described by Kan et 01. (1974) and several groups have developed a large experience with this method (Kan et 01. 1977 , Fairweather et 01. 1978 . The aim is to perforate a fetal vessel on the chorionic plate, cause some bleeding into the amniotic fluid, and to aspirate the resulting mixture. It has an unacceptably high fetal mortality (lQ-15%) mainly due to fetal haemorrhage, because the blood sampling needle is 20 gauge, as distinct from 27 gauge in fetoscopy. Also, many blood samples have to be taken, in the hope that some will contain fetal red cells. The procedure has to be repeated one or more times in up to 50% of patients. Similar in aim, but under direct vision with fetoscopy, was the method devised by . After puncture of a fetal vessel on the chorionic plate, the jet of blood could be seen in the amniotic fluid and was aspirated. Dangerous fetal blood loss was thought to be rare (Hobbins & Mahoney 1975) and there were no fetal deaths due to haemorrhage. Such samples usually contained a higher proportion of fetal red cells than those obtained by placentocentesis, and the procedure needed to be repeated only infrequently. However, both methods incur a risk of fetomaternal haemorrhage, and various strategies had to be designed to deal with samples that contained more maternal blood than fetal. Enrichment of the fetal cells could be produced by treatment with anti-i serum, or preferential haemolysis of maternal cells. Absence of maternal reticulocytes in a mixed sample could be assured by transfusing the patient with four units of blood seven to ten days before sampling. The technique described here arose out of a dissatisfaction with mixed samples which, although adequate for the diagnosis of haemoglobinopathies, were less reliable for the assay of substances in the fetal plasma, e.g. factors VIII and IX, creatine phosphokinase. It was found that the larger the vessel selected for puncture, the better the chance of aspirating pure fetal blood from within the lumen of the vessel. This is optimal at the umbilical cord insertion, where the vessels are at their largest and where puncture is easy because they are relatively fixed. There is almost no risk of entering the maternal circulation (intervillous space) and hence of contamination of the sample with maternal blood or of causing fetomaternal haemorrhage. Finally, fetal haemorrhage seems to be much less than from the chorionic plate vessels; withdrawal of the needle tip from a cord insertion vessel usually results in only a small trickle of blood into the amniotic cavity. Thus the quantity of fetal blood loss is only a little more than that aspirated, and should further sampling be necessary, this is not hindered by amniotic fluid turbidity. Such efficient haemostasis at this site is probably due to greater elasticity and muscularity of the vascular wall, and to the amnion and Wharton's jelly firmly encompassing and supporting the vessels; on the chorionic plate, the fetal vessels have no support and the amnion is easily elevated and displaced. The high success rate and reliability of this technique has enabled us to omit preoperative blood transfusion of the mother in cases where the fetus is at risk of a haemoglobinopathy.
Initially, fetoscopy was used for the posterior placenta only, and placentocentesis for the anterior. With increasing experience and confidence, most fetoscopists have found the majority of anterior placentas amenable to this technique (Benzie & Pirani 1977) .We have not used placentocentesis at all, and have been defeated by only two very difficult anterior placentas. In one, the margin of the placenta was perforated, intra-amniotic bleeding (maternal) made sampling impossible, and the fetus died inutero of placental abruption. Inthe other, placental damage was avoided and the entry of the fetoscope was bloodless, but the cord insertion was too distant to be sampled.
When fetoscopy is being done to exclude a physical defect, particular attention must be paid to the fetal position. The preparatory scan is performed without the patient (and fetus) being sedated. If the chances of seeing the fetal area in question are poor, it is best to defer the procedure since, in the absence' of sedation, the fetus may change its position. Thus, failed fetoscopy should be avoidable. If, on the other hand, a safe insertion site is found that will enable adequate examination, diazepam and pentazocine are given rapidly intravenously to 'freeze' the fetus in its favourable position. Total fetal visualization is not a practical proposition and the more precisely the objectives of the examination are defined, the better the chances of success. Detailed knowledge of the nature, incidence, distribution and extent of the defect should be available and close cooperation with a geneticist is essential. It is probable that the majority of limb defects will be diagnosed by ultrasonic examination, with fetoscopy providing a back-up in cases of doubt.
. The main indications for fetoscopy are shown in Tables 2 and 3; in the United Kingdom, haemophilia will be the most important. A list of potentially diagnosable conditions would be very long and consist of rarities. Other authors have been able to exclude a variety of limb defects (Rauskolb & Fuhrmann 1978 , Laurence et al. 1975 ), Laurence-Moon-Biedl syndrome and arthrogryposis multiplex (Benzie et al. 1976 ) and to diagnose chronic granulomatous disease in utero (Newburger et al. 1979) . Patients at risk of having a fetus with a chromosome abnormality, or a metabolic disorder, who book late, i.e. 18 to 20 weeks' gestation, may benefit from fetoscopic blood sampling rather than wait several weeks for amniotic fluid cells to grow.
A karyotype can be obtained from fetal lymphocytes in three days and an enzyme assay on fetal blood the same day (Fensom et al. 1979) .
Fetoscopy is an invasive procedure and of prime concern is the fetal mortality. Table 4 shows that this is reassuringly low and although numbers are still small, an incidence of 3-5% is found by other workers (Hobbins 1979) . In the present series, all the babies that have been delivered so far have been normal on follow up.
In conclusion, fetoscopy can be performed safely and reliably and is established as an important diagnostic tool. Hopefully, in the future it may have therapeutic applications, but at present these are speculative.
